This inventor holds 2 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2001-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2005
Title: Seturan B Katti: Innovator in Peptide Research
Introduction
Seturan B Katti is a notable inventor based in Lucknow, India. He has made significant contributions to the field of peptide research, particularly in the diagnosis of Aspergillus fumigatus. With a total of 2 patents to his name, Katti's work is recognized for its innovative approach to addressing medical challenges.
Latest Patents
Katti's latest patents focus on polypeptides that are useful for the diagnosis of Aspergillus fumigatus. The first patent describes novel peptide sequences derived from the immunodominant region of an 18 kD major allergen/antigen. These sequences include amino acid ranges such as aa 6-22, aa 10-20, aa 6-20, aa 14-20, aa 10-22, and aa 6-13. The invention also covers peptide sequences that result from modifications through substitution, addition, or deletion of one or more amino acids, which alter specified properties.
Career Highlights
Seturan B Katti is affiliated with the Council of Scientific and Industrial Research, where he conducts his research. His work has been instrumental in advancing the understanding of allergens and their implications in health.
Collaborations
Katti collaborates with esteemed colleagues such as Priyanka Priyadarsiny and Puranam U Sarma, contributing to a dynamic research environment.
Conclusion
Seturan B Katti's innovative work in peptide research highlights his commitment to improving diagnostic methods for Aspergillus fumigatus. His contributions are paving the way for advancements in medical science and allergy research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile